NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹25 Cr | ₹-69 Cr | ₹-136 Cr | ₹38 Cr | ₹-114 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹-136 Cr |
| Mar2022 | ₹38 Cr |
| Mar2021 | ₹-114 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹-136 Cr | Negative | |
| Mar2022 | ₹38 Cr | Positive | |
| Mar2021 | ₹-114 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,120.4 Cr | 5% | 7.8% | 46.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 5% |
7.8% |
46.7% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses